# Efficacy Comparison of Warfarin Versus Rivaroxaban CVT

> **NCT03747081** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Isfahan University of Medical Sciences** · enrollment: 50 (estimated)

## Conditions studied

- Cerebral Venous Thrombosis

## Interventions

- **DRUG:** Rivaroxaban
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT03747081
- **Lead sponsor:** Isfahan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-05-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03747081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03747081, "Efficacy Comparison of Warfarin Versus Rivaroxaban CVT". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03747081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*